Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: INFY stock price vs ORCL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Implied fair value · at INFY's multiple
Needs INFY P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
INFOSYS LIMITED · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
ORACLE CORP · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Accenture plc
INFY vs ACN
COGNIZANT TECHNOLOGY SOLUTIONS CORP
INFY vs CTSH
INTERNATIONAL BUSINESS MACHINES CORP
INFY vs IBM
DXC Technology Co
INFY vs DXC
Microsoft Corporation
INFY vs MSFT
Amazon.com, Inc.
INFY vs AMZN
Alphabet Inc.
INFY vs GOOGL
Cisco Systems, Inc.
INFY vs CSCO
Salesforce, Inc.
INFY vs CRM
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe INFY can sustain ORCL-style rerating without closing its growth and margin gap to ORCL, then holding or accumulating makes sense because INFY is cheap on P/E and P/S relative to ORCL; if you require stronger quality confirmation, wait because the DCF range and F-Score both argue for caution.
INFY trades at 17.2x P/E and 2.8x P/S versus ORCL at 56.4x P/E and 12.3x P/S, so it is much cheaper on relative multiples. However, the DCF range of $4.38-$5.92 sits well below the current price of $13.08, while ORCL-implied range of $18.62-$57.01 suggests some upside if INFY were rerated closer to ORCL.
Supporting Metrics
